These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6803871)
41. Comparative trial of felodipine and nifedipine in refractory hypertension. Aberg H; Lindsjö M; Mörlin B Drugs; 1985; 29 Suppl 2():117-23. PubMed ID: 3886357 [TBL] [Abstract][Full Text] [Related]
42. [Hypertension treatment with nifedipine (Corinfar)]. Rühle W; Berndt H Z Arztl Fortbild (Jena); 1983; 77(12):523-5. PubMed ID: 6349148 [No Abstract] [Full Text] [Related]
43. Comparison of AQ-A 39 with propanolol and placebo in ischaemic heart disease. Gilfrich HJ; Oberhoffer M; Witzke J Eur Heart J; 1987 Dec; 8 Suppl L():147-51. PubMed ID: 3330526 [TBL] [Abstract][Full Text] [Related]
44. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Lynch P; Dargie H; Krikler S; Krikler D Br Med J; 1980 Jul; 281(6234):184-7. PubMed ID: 6773613 [TBL] [Abstract][Full Text] [Related]
45. Effects of calcium antagonism and beta-blockade on haemodynamic responses to stress. McInnes GT; Findlay IN; Murray GD; Dargie HJ Nephron; 1987; 47 Suppl 1():128-31. PubMed ID: 3320786 [TBL] [Abstract][Full Text] [Related]
46. [Effects of nifedipine in the treatment of effort stable angina: a double blind study (author's transl)]. Rengo F; De Caprio L; Bonaduce D; Carlomagno A; Scarafile P; Petretta M; Condorelli M G Ital Cardiol; 1978; 8(2):153-7. PubMed ID: 417957 [TBL] [Abstract][Full Text] [Related]
47. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic). Aoki K; Sato K Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418 [TBL] [Abstract][Full Text] [Related]
48. The immediate hypotensive effect of oral nifedipine. Chia BL; Ee B; Tan A; Choo M Curr Med Res Opin; 1982; 8(3):139-41. PubMed ID: 7128185 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension. Beer N; Gallegos I; Cohen A; Klein N; Sonnenblick E; Frishman W Chest; 1981 May; 79(5):571-4. PubMed ID: 7226935 [TBL] [Abstract][Full Text] [Related]
50. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. Floras JS; Jones JV; Hassan MO; Sleight P Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568 [TBL] [Abstract][Full Text] [Related]
51. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure. Pandhi P; Sharma PL; Sharma BK; Wahi PL Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):249-53. PubMed ID: 3525424 [TBL] [Abstract][Full Text] [Related]
52. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol. Cantor A; Cristal N J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309 [TBL] [Abstract][Full Text] [Related]
53. Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension. Aoki K; Sato K; Kawaguchi Y; Yamamoto M Eur J Clin Pharmacol; 1982; 23(3):197-201. PubMed ID: 7173292 [TBL] [Abstract][Full Text] [Related]
54. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension. Antani J; Buckle JW; Turner J; Cohen M Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463 [TBL] [Abstract][Full Text] [Related]
55. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine. Welzel D; Burger KJ Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644 [TBL] [Abstract][Full Text] [Related]
56. [Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)]. Brügmann U; Blasini R; Goebel G; Mannes A; Dirschinger J; Rudolph W Herz; 1982 Apr; 7(2):117-25. PubMed ID: 7044932 [No Abstract] [Full Text] [Related]
57. [Controlled study on the treatment of hypertension with verapamil in retard form]. Belz GG; Spies G Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562 [TBL] [Abstract][Full Text] [Related]
58. Modification of exercise performance by sharp reduction of blood pressure. A study in patients with uncomplicated hypertension. Agostoni PG; Doria E; Alimento M; Riva S; Muratori M; Tamborini G Chest; 1993 Dec; 104(6):1755-8. PubMed ID: 8252957 [TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study. Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366 [TBL] [Abstract][Full Text] [Related]
60. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise. Danielsson A; Bjerle P; Ek B; Steen L; Suhr O Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]